Lion Corporation Report issue

For profit Phase 3
Founded: Tokyo Japan (2018)
Status: Left NME R&D (2016)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now